Kathleen Marie Hoey, MD | |
333 Mount Hope Ave, Rockaway, NJ 07866-1645 | |
(973) 895-6601 | |
Not Available |
Full Name | Kathleen Marie Hoey |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 36 Years |
Location | 333 Mount Hope Ave, Rockaway, New Jersey |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1619193240 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 25MA07384200 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Atlantic Home Care & Hospice | Morristown, NJ | Home health agency |
Visiting Nurse Assoc Of Northern New Jersey, Inc | Morristown, NJ | Home health agency |
Morristown Medical Center | Morristown, NJ | Hospital |
Hackettstown Medical Center | Hackettstown, NJ | Hospital |
Saint Clare's Hospital/ Denville Campus | Denville, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Practice Associates Medical Group | 5890703177 | 1116 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the winners of the first triennial IEA Elsevier John Wilson Award.
Teva Pharmaceutical Industries Ltd. today announced that data from four late-stage studies examining QNASL (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) symptoms, will be presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston, Mass., November 3-8, 2011.
Hospitalization for rotavirus infections decreased by > 70% following the introduction of a vaccine program in Ontario, Canada, according to a study published May 11, 2016 in the open-access journal PLOS ONE by Sarah Wilson from Public Health Ontario and the Institute for Clinical Evaluative Sciences, Canada, and colleagues.
Circadian Technologies Limited today released data demonstrating that its lead anti-cancer therapeutic, VGX-100, significantly inhibits tumour growth in a variety of different animal models (tumour xenografts) of human cancer.
› Verified 7 days ago
Entity Name | Practice Associates Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the winners of the first triennial IEA Elsevier John Wilson Award.
Teva Pharmaceutical Industries Ltd. today announced that data from four late-stage studies examining QNASL (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) symptoms, will be presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston, Mass., November 3-8, 2011.
Hospitalization for rotavirus infections decreased by > 70% following the introduction of a vaccine program in Ontario, Canada, according to a study published May 11, 2016 in the open-access journal PLOS ONE by Sarah Wilson from Public Health Ontario and the Institute for Clinical Evaluative Sciences, Canada, and colleagues.
Circadian Technologies Limited today released data demonstrating that its lead anti-cancer therapeutic, VGX-100, significantly inhibits tumour growth in a variety of different animal models (tumour xenografts) of human cancer.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Kathleen Marie Hoey, MD Po Box 416457, Boston, MA 02241-6457 Ph: () - | Kathleen Marie Hoey, MD 333 Mount Hope Ave, Rockaway, NJ 07866-1645 Ph: (973) 895-6601 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the winners of the first triennial IEA Elsevier John Wilson Award.
Teva Pharmaceutical Industries Ltd. today announced that data from four late-stage studies examining QNASL (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) symptoms, will be presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston, Mass., November 3-8, 2011.
Hospitalization for rotavirus infections decreased by > 70% following the introduction of a vaccine program in Ontario, Canada, according to a study published May 11, 2016 in the open-access journal PLOS ONE by Sarah Wilson from Public Health Ontario and the Institute for Clinical Evaluative Sciences, Canada, and colleagues.
Circadian Technologies Limited today released data demonstrating that its lead anti-cancer therapeutic, VGX-100, significantly inhibits tumour growth in a variety of different animal models (tumour xenografts) of human cancer.
› Verified 7 days ago